[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.121.0. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
May 9, 2007

The Enigma of Drug-Eluting StentsHope, Hype, Humility, and Advancing Patient Care

Author Affiliations
 

Author Affiliations: Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

JAMA. 2007;297(18):2028-2030. doi:10.1001/jama.297.18.2028

Interventional cardiology is an iterative science. Advances come in spurts as interventionalists gradually become increasingly familiar with its technologies and limitations. This iterative learning process in the use of percutaneous coronary intervention (PCI) has been tremendous over the last 3 decades. While adverse events were frequent and restenosis was common in the first decade, PCI procedures did relieve symptoms for patients with coronary disease. In the second decade of PCI use, new techniques were developed to scrape, burn, or excise plaque, in an attempt to achieve better outcomes. While there was much hope and hype with these approaches, they all had fundamental problems that prevented their broader use.

First Page Preview View Large
First page PDF preview
First page PDF preview
×